Functional consequences of sarcopenia and dynapenia in the elderly.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search methodology or original data synthesis
PubMed 20154609 · doi:10.1097/MCO.0b013e328337819e
What was done
Narrative review discussing the societal burden of age-related physical function decline, the physiological mechanisms underlying dynapenia (muscle weakness in older age), and perspectives on the distinction between sarcopenia and dynapenia based on published longitudinal aging studies.
What was found
The abstract reports no numerical data, sample sizes, or effect estimates. It notes that longitudinal epidemiological studies associate dynapenia with increased mortality and physical disability even after adjusting for sarcopenia. It also reports that dynapenia is driven by combined alterations in muscle quantity, contractile quality, and neural activation rather than mass alone.
Why it matters
This review distinguishes age-related loss of strength (dynapenia) from loss of mass (sarcopenia), emphasizing that neuromuscular function rather than muscle quantity alone drives physical independence and mortality risk.
Limits
As a narrative review, it lacks systematic search methodology, risk-of-bias assessment, or pooled quantitative data. No specific numbers or confidence intervals are reported in the abstract, and the relative contributions of mechanisms across different muscle groups and populations remain unquantified.
Cited by
- supports During aging, the loss of muscle strength is greater than can be explained solely by the loss of muscle mass.